Trophectoderm Biopsy is Associated with Adverse Obstetric Outcomes Rather Than Neonatal Outcomes

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2023 Mar 4

PMID 36870973

Authors

Hui Ji

Mian-Qiu Zhang

Qiao Zhou

Song Zhang

Li Dong

Xiu-Ling Li

Chun Zhao

Hui Ding

Xiu-Feng Ling

Affiliations

Soon will be listed here.

Abstract

Background: With the wide application of preimplantation genetic testing (PGT) with trophectoderm (TE) biopsy, the safety of PGT has always been a concern. Since TE subsequently forms the placenta, it is speculated that the removal of these cells was associated with adverse obstetrical or neonatal outcomes after single frozen-thawed blastocyst transfer (FBT). Previous studies report contradictory findings with respect to TE biopsy and obstetric and neonatal outcomes.

Methods: We conducted a retrospective cohort study including 720 patients with singleton pregnancies from single FBT cycles who delivered at the same university-affiliated hospital between January 2019 and March 2022. The cohorts were divided into two groups: the PGT group (blastocysts with TE biopsy, n = 223) and the control group (blastocysts without biopsy, n = 497). The PGT group was matched with the control group by propensity score matching (PSM) analysis at a ratio of 1:2. The enrolled sample sizes in the two groups were 215 and 385, respectively.

Results: Patient demographic characteristics were comparable between the groups after PSM except for the proportion of recurrent pregnancy loss, which was significantly higher in the PGT cohort (31.2 vs. 4.2%, P < 0.001). Patients in the PGT group had significantly higher rates of gestational hypertension (6.0 vs. 2.6%, adjusted odds ratio (aOR) 2.91, 95% confidence interval (CI) 1.18-7.18, P = 0.020) and abnormal umbilical cord (13.0 vs. 7.8%, aOR 1.94, 95% CI 1.08-3.48, P = 0.026). However, the occurrence of premature rupture of membranes (PROM) (12.1 vs. 19.7%, aOR 0.59, 95% CI 0.35-0.99, P = 0.047) was significantly lower in biopsied blastocysts than in unbiopsied embryos. There were no significant differences in regard to other obstetric and neonatal outcomes between the two groups.

Conclusions: Trophectoderm biopsy is a safe approach, as the neonatal outcomes from biopsied and unbiopsied embryos were comparable. Furthermore, PGT is associated with higher risks of gestational hypertension and abnormal umbilical cord but may have a protective effect on PROM.

References

He H, Jing S, Lu C, Tan Y, Luo K, Zhang S . Neonatal outcomes of live births after blastocyst biopsy in preimplantation genetic testing cycles: a follow-up of 1,721 children. Fertil Steril. 2019; 112(1):82-88. DOI: 10.1016/j.fertnstert.2019.03.006. View

Wu H, Zhou P, Lin X, Wang S, Zhang S . Endometrial preparation for frozen-thawed embryo transfer cycles: a systematic review and network meta-analysis. J Assist Reprod Genet. 2021; 38(8):1913-1926. PMC: 8417182. DOI: 10.1007/s10815-021-02125-0. View

Hou W, Shi G, Ma Y, Liu Y, Lu M, Fan X . Impact of preimplantation genetic testing on obstetric and neonatal outcomes: a systematic review and meta-analysis. Fertil Steril. 2021; 116(4):990-1000. DOI: 10.1016/j.fertnstert.2021.06.040. View

Zhang W, von Versen-Hoynck F, Kapphahn K, Fleischmann R, Zhao Q, Baker V . Maternal and neonatal outcomes associated with trophectoderm biopsy. Fertil Steril. 2019; 112(2):283-290.e2. PMC: 6527329. DOI: 10.1016/j.fertnstert.2019.03.033. View

Bay B, Ingerslev H, Lemmen J, Degn B, Rasmussen I, Kesmodel U . Preimplantation genetic diagnosis: a national multicenter obstetric and neonatal follow-up study. Fertil Steril. 2016; 106(6):1363-1369.e1. DOI: 10.1016/j.fertnstert.2016.07.1092. View

Swanson K, Huang D, Kaing A, Blat C, Rosenstein M, Mok-Lin E . Is Preimplantation Genetic Testing Associated with Increased Risk of Abnormal Placentation After Frozen Embryo Transfer?. Am J Perinatol. 2020; 38(2):105-110. DOI: 10.1055/s-0040-1714681. View

Van Heertum K, Lam L, Richardson B, Cartwright M, Mesiano S, Cameron M . Blastocyst Vitrification and Trophectoderm Biopsy Cumulatively Alter Embryonic Gene Expression in a Mouse Model. Reprod Sci. 2021; 28(10):2961-2971. DOI: 10.1007/s43032-021-00560-z. View

Zhang J, Liu H, Mao X, Chen Q, Si J, Fan Y . Effect of endometrial thickness on birthweight in frozen embryo transfer cycles: an analysis including 6181 singleton newborns. Hum Reprod. 2019; 34(9):1707-1715. DOI: 10.1093/humrep/dez103. View

Yao Q, Chen L, Liang Y, Sui L, Guo L, Zhou J . Blastomere removal from cleavage-stage mouse embryos alters placental function, which is associated with placental oxidative stress and inflammation. Sci Rep. 2016; 6:25023. PMC: 4842963. DOI: 10.1038/srep25023. View

10.

Sites C, Bachilova S, Gopal D, Cabral H, Coddington C, Stern J . Embryo biopsy and maternal and neonatal outcomes following cryopreserved-thawed single embryo transfer. Am J Obstet Gynecol. 2021; 225(3):285.e1-285.e7. PMC: 8429112. DOI: 10.1016/j.ajog.2021.04.235. View

11.

Murphy-Kaulbeck L, Dodds L, Joseph K, Van den Hof M . Single umbilical artery risk factors and pregnancy outcomes. Obstet Gynecol. 2010; 116(4):843-850. DOI: 10.1097/AOG.0b013e3181f0bc08. View

12.

Li M, Kort J, Baker V . Embryo biopsy and perinatal outcomes of singleton pregnancies: an analysis of 16,246 frozen embryo transfer cycles reported in the Society for Assisted Reproductive Technology Clinical Outcomes Reporting System. Am J Obstet Gynecol. 2020; 224(5):500.e1-500.e18. DOI: 10.1016/j.ajog.2020.10.043. View

13.

Awadalla M, Park K, Latack K, McGinnis L, Ahmady A, Paulson R . Influence of Trophectoderm Biopsy Prior to Frozen Blastocyst Transfer on Obstetrical Outcomes. Reprod Sci. 2021; 28(12):3459-3465. DOI: 10.1007/s43032-021-00552-z. View

14.

Hasson J, Limoni D, Malcov M, Frumkin T, Amir H, Shavit T . Obstetric and neonatal outcomes of pregnancies conceived after preimplantation genetic diagnosis: cohort study and meta-analysis. Reprod Biomed Online. 2017; 35(2):208-218. DOI: 10.1016/j.rbmo.2017.05.003. View

15.

Gleicher N, Albertini D, Barad D, Homer H, Modi D, Murtinger M . The 2019 PGDIS position statement on transfer of mosaic embryos within a context of new information on PGT-A. Reprod Biol Endocrinol. 2020; 18(1):57. PMC: 7257212. DOI: 10.1186/s12958-020-00616-w. View

16.

Schachter M, Tovbin Y, Arieli S, Friedler S, Ron-El R, Sherman D . In vitro fertilization is a risk factor for vasa previa. Fertil Steril. 2002; 78(3):642-3. DOI: 10.1016/s0015-0282(02)03253-3. View

17.

Zheng W, Yang S, Yang C, Ren B, Sun S, Liu Y . Perinatal outcomes of singleton live births after preimplantation genetic testing during single frozen-thawed blastocyst transfer cycles: a propensity score-matched study. Fertil Steril. 2022; 117(3):562-570. DOI: 10.1016/j.fertnstert.2021.12.020. View

18.

Matsuzaki S, Ueda Y, Matsuzaki S, Nagase Y, Kakuda M, Lee M . Assisted Reproductive Technique and Abnormal Cord Insertion: A Systematic Review and Meta-Analysis. Biomedicines. 2022; 10(7). PMC: 9312931. DOI: 10.3390/biomedicines10071722. View

19.

Handyside A, Kontogianni E, Hardy K, Winston R . Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990; 344(6268):768-70. DOI: 10.1038/344768a0. View

20.

Sunkara S, Antonisamy B, Selliah H, Kamath M . Pre-term birth and low birth weight following preimplantation genetic diagnosis: analysis of 88 010 singleton live births following PGD and IVF cycles. Hum Reprod. 2016; 32(2):432-438. DOI: 10.1093/humrep/dew317. View